Off-Site Waste. If necessary, Hospira shall hire, direct and pay all costs for a waste contractor to remove all Waste from Hospira’s manufacturing facility for Product consistent with the Product’s MSDS. The costs associated with the removal of Specially Regulated Waste shall be borne by Theravance. Hospira shall only dispose of Specially Regulated Waste at sites and through waste management vendors that have been approved in writing by Theravance, whose approval shall not be withheld unreasonably. Hospira shall document the destruction of any Specially Regulated Waste in writing and provide copies of such written documentation to an authorized representative of Theravance. Theravance maintains the right, but not the obligation, to witness the actual disposal of Specially Regulated Waste. Theravance shall, upon request by Hospira, provide the MSDS for the API and the MSDS for the Product to Hospira. ***CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.
Appears in 3 contracts
Samples: Technology Transfer and Supply Agreement (Theravance Biopharma, Inc.), Technology Transfer and Supply Agreement (Theravance Biopharma, Inc.), Technology Transfer and Supply Agreement (Theravance Inc)
Off-Site Waste. If necessary, Hospira shall hire, direct and pay all costs for a waste contractor to remove all Waste from Hospira’s manufacturing facility for Product consistent with the Product’s Material Safety Data Sheets (“MSDS”). The pre-approved costs associated with the removal of Specially Regulated Waste shall be borne by TheravanceRevance. Hospira shall only dispose of Specially Regulated Waste at sites and through waste management vendors that have been approved in writing by TheravanceRevance, whose approval shall not be withheld unreasonably. Hospira shall document the destruction of any Specially Regulated Waste in writing and provide copies of such written documentation to an authorized representative of TheravanceRevance. Theravance Revance maintains the right, but not the obligation, to witness the actual disposal of Specially Regulated Waste. Theravance Revance shall, upon request by Hospira, provide the MSDS for the API and the MSDS for the Product to Hospira. ***CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS[ ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Appears in 1 contract
Samples: Development and Supply Agreement (Revance Therapeutics, Inc.)
Off-Site Waste. If necessary, Hospira shall hire, direct and pay all reasonable agreed costs for a waste contractor to remove all Waste from Hospira’s manufacturing facility for Product the Products consistent with the Product’s Products’ Material Safety Data Sheets (“MSDS”). The reasonable, agreed costs associated with the removal of Specially Regulated Waste shall be borne by TheravanceMediciNova. Hospira shall only dispose of Specially Regulated Waste at sites and through waste management vendors that have been approved in writing by TheravanceMediciNova, whose approval shall not be withheld unreasonably. Hospira shall document the destruction of any Specially Regulated Waste in writing and provide copies of such written documentation to an authorized representative of TheravanceMediciNova. Theravance MediciNova maintains the right, but not the obligation, to witness the actual disposal of Specially Regulated Waste. Theravance MediciNova shall, upon request by Hospira, provide the MSDS for the API and the MSDS for the Product Products to Hospira. ***CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONSAll other costs for waste disposal shall be Hospira’s.
Appears in 1 contract
Off-Site Waste. If necessary, Hospira shall hire, direct and pay all costs for a waste contractor to remove all Product-related Waste from Hospira’s manufacturing facility for Product Facility, consistent with the each Product’s Material Safety Data Sheets (“MSDS”). The costs associated with the removal of Specially Regulated Waste Waste, as set forth in the relevant Project SOW, shall be borne by TheravanceGenzyme. Hospira shall only dispose of Specially Regulated Waste at sites and through waste management vendors that have been approved in writing by TheravanceGenzyme, whose approval shall not [**] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. be withheld unreasonablyunreasonably withheld. Hospira shall document the destruction of any Specially Regulated Waste in writing and provide copies of such written documentation to an authorized representative of TheravanceGenzyme. Theravance Genzyme maintains the right, but not the obligation, to witness the actual disposal of Specially Regulated Waste. Theravance Genzyme shall, upon request by Hospira, provide the MSDS for the API Bulk and the MSDS for the each Product to Hospira. ***CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.
Appears in 1 contract